Prognosis impact of multiple novel lymphocyte-based inflammatory indices in patients with initially diagnosed

Yi Gao1, Geng Bai1, Yuqing Li1

  • 1Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin, China.

PubMed

Insights

The novel Systemic Immune Inflammation Response Index (SIIRI) is a strong predictor of major adverse cardiovascular events (MACEs) in patients with coronary artery disease (CAD). Combining SIIRI with traditional risk factors improves MACE prediction accuracy.

Area of Science:

  • Cardiology
  • Inflammation Research
  • Biomarker Discovery

Background:

  • Coronary artery disease (CAD) poses a significant global health burden.
  • Novel inflammatory markers are being investigated for their prognostic value in CAD.
  • Lymphocyte-based inflammatory markers offer potential insights into CAD pathogenesis and progression.

Purpose of the Study:

  • To evaluate six novel lymphocyte-based inflammatory markers for predicting major adverse cardiovascular events (MACEs) in newly diagnosed CAD patients.
  • To determine the independent predictive value of these markers, including the Systemic Immune Inflammation Response Index (SIIRI) and Platelet-Lymphocyte Ratio (PLR).
  • To assess the incremental predictive ability of these markers when added to traditional cardiovascular risk factors.

Main Methods:

  • A cohort of 959 patients with newly diagnosed CAD was enrolled.
  • Patients were followed for MACEs (cardiovascular death, myocardial infarction, stroke).
  • Cox regression analysis was used to evaluate the association between inflammatory markers and MACEs.

Main Results:

  • During follow-up, 23.9% of patients experienced MACEs.
  • The Systemic Immune Inflammation Response Index (SIIRI) and Platelet-Lymphocyte Ratio (PLR) were identified as independent predictors of MACEs.
  • SIIRI demonstrated superior predictive performance, significantly improving model discrimination and reclassification compared to traditional risk factors alone.

Conclusions:

  • SIIRI is an independent and superior predictor of MACEs in newly diagnosed CAD patients.
  • The integration of SIIRI with traditional risk factors enhances the accuracy of MACE prediction.
  • SIIRI represents a promising novel biomarker for risk stratification in CAD management.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64
Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
3